Published on 30 May 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Significant control over Zevra Therapeutics by retail investors implies that the general public has more power to influence management and governance-related decisions39% of the business is held by the top 25 shareholders 28% of Zevra Therapeutics is held by Institutions
A look at the shareholders of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) can tell us which group is most powerful. With 59% stake, retail investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.